As a recognized worldwide leader in cardiovascular disease (CVD) testing, Siemens Healthcare Diagnostics provides a comprehensive and expanding menu of cardiac biomarkers that help manage patients throughout the continuum of disease.
Siemens was the first company to offer a high sensitivity C-reactive protein (hsCRP) assay with a cardiac-specific claim.
Learn more
Siemens is the only company that offers a choice in natriuretic peptide testing across multiple instrument platforms.
Learn more
Siemens is the only company offering multiple solutions for high-sensitivity troponin I* testing that meets the current guidelines for MI diagnosis.
Learn more
*Defined by the ESC/ACC committee as an imprecision level of ≤10% at the 99th percentile of normal.
Siemens offers MPO testing across multiple instrument solutions to help provide a more complete clinical picture of the CVD patient.
Learn more